STAT October 9, 2020
Helen Branswell and Ed Silverman

The race to develop Covid-19 vaccines could well see some Americans vaccinated before the end of 2020 — less than a year after the world first learned a new virus was causing a dangerous new form of pneumonia in China.

The design, testing, and mass production of multiple vaccines has never been attempted on this type of timeline, making this moment a turning point in the development of vaccines to respond to new disease threats.

But the complexity of that work may pale in comparison to what comes next — the rollout of hundreds of millions of doses of never-before-used vaccines across the United States and, eventually, around the world.

Expect snafus. Expect confusion. Despite the best of intentions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Govt Agencies, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Public Health / COVID
CDC probe into fake Botox grows: 5 notes
Over 70% of workers around the world are exposed to excessive heat each year, UN body finds
On Earth Day, Climate Change’s Impact On Infectious Diseases Looms
Bird flu a 'great concern' to public health: WHO
Heat-related ED visits skyrocketed last year. What does that mean for 2024?

Share This Article